首页> 外文会议>PLM 2013 >Product Portfolio Management: An Analysis of a Large Medical Device Company
【24h】

Product Portfolio Management: An Analysis of a Large Medical Device Company

机译:产品组合管理:大型医疗器械公司分析

获取原文

摘要

This paper focuses on product portfolio management in a large multinational medical device organization. The contribution of this research is to provide insights into the nature, composition and decision making processes of product portfolios in a real world setting. The research is important because portfolio management decisions have a significant impact and influence the performance at each stage in the product life cycle. Results of the study indicate that portfolio management is a complex process in general but particularly challenging when dealing with technology development projects or innovative new products as unchartered waters are difficult to assess. We found that there are challenges with transparency and that stakeholders need fact based and information driven decisions. There is a need for better up front planning and systems to guide the process. Consistent criteria should be used to select and prioritize projects to facilitate better comparative ranking and allow for balanced portfolios, as well better resource distribution. However we also found that these criteria may change depending on the stage in the lifecycle.
机译:本文侧重于大型跨国医疗器械组织中的产品组合管理。本研究的贡献是提供对现实世界环境中产品组合的性质,组成和决策过程的见解。研究很重要,因为产品组合管理决策具有显着的影响并影响产品生命周期中每个阶段的性能。研究结果表明,投资组合管理是一般的复杂过程,但在处理技术开发项目或创新的新产品时,难以评估,难以评估。我们发现透明度存在挑战,利益相关者需要基于事实和信息驱动的决策。需要更好地提高前部规划和系统来指导该过程。应使用一致的标准选择和优先考虑项目以促进更好的比较排名,并允许平衡投资组合,以及资源分布。然而,我们还发现,这些标准可能会根据生命周期中的阶段而改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号